April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Effect of a Combined Patching and Atropine Treatment in Patients With Anisometropic Amblyopia With Microtropia for the Prevention of Amblyopia Recurrence
Author Affiliations & Notes
  • F. Matsumoto
    Ophthalmology, Kinki Univ Sch of Medicine,Sakai-Hospital, Sakai, Japan
  • A. Yamabe
    Ophthalmology, Kinki Univ Sch of Medicine,Sakai-Hospital, Sakai, Japan
  • H. Yamamoto
    Ophthalmology, Kinki Univ Sch of Medicine,Sakai-Hospital, Sakai, Japan
  • Y. Nakao
    Ophthalmology, Kinki Univ Sch of Medicine,Sakai-Hospital, Sakai, Japan
  • A. Wakayama
    Ophthalmology, Kinki Univ Sch of Medicine, Osaka-sayama, Japan
  • Y. Shimomura
    Ophthalmology, Kinki Univ Sch of Medicine, Osaka-sayama, Japan
  • Footnotes
    Commercial Relationships  F. Matsumoto, None; A. Yamabe, None; H. Yamamoto, None; Y. Nakao, None; A. Wakayama, None; Y. Shimomura, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4710. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Matsumoto, A. Yamabe, H. Yamamoto, Y. Nakao, A. Wakayama, Y. Shimomura; Effect of a Combined Patching and Atropine Treatment in Patients With Anisometropic Amblyopia With Microtropia for the Prevention of Amblyopia Recurrence. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4710.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously reported that anisomertopic amblyopia with microtropia often recurs after a patching treatment. To prevent the recurrence, we investigated the effect of a combined patching and atropine occlusion treatment in patients with anisometropic amblyopia with microtropia.

Methods: : Eight patients (mean age, 69±10 months) with anisometropic amblyopia with microtropia were included. The mean refractive errors for the amblyopic and fellow eyes were +5.69±1.11D and +2.15±1.5D (spherical), respectively. Patient’s pre-treatment visual acuity (VA) of the amblyopic eye ranged from 0.30-1.04 logMAR. The treatment protocol was as follows: (1) an initial patching time of eight hours or longer per day was set, (2) the patching time was reduced to 3-5 hours per day depending to the patient’s age when the VA ceiling of the amblyopic eye was reached, (3) if VA of the amblyopic eye remained stable, treatment of 1% atropine eye drops once per day was started on the fellow eye. During a follow-up period of 6-72 months, recurrence of amblyopia was determined based on the VA stability of the amblyopic eye.

Results: : Seven (87.5%) of the eight patients, had improved VA of 0 logMAR in the amblyopic eye after the patching treatment and were able to maintain their VA after the atropine occlusion treatment. The other patient (12.5%) had improved VA of 0.15 logMAR after the patching treatment and the VA was further improved after the atropine occlusion treatment. The overall treatment required 8-17 months; and the respective means were 5.14 months for the patching treatment of 8 hours or longer per day, 2 months for the patching treatment of 3-5 hours per day, and 3.14 months for the atropine occlusion treatment. None of the patients experienced amblyopia recurrence during the follow-up period.

Conclusions: : Because atropine occlusion promotes binocular rivalry under binocular condition, an atropine occlusion treatment following patching can effectively prevent recurrence of amblyopia.

Keywords: amblyopia • visual acuity • strabismus: treatment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×